Loading data for SBIO — first visit, this takes a few seconds.

ALPS Medical Breakthroughs ETF

NYSEArca: SBIO · Prix en temps réel · USD
66.86
-0.23 (-0.34%)
À la clôture : Sep 01, 2026, 7:59 PM

ALPS Medical Breakthroughs ETF (SBIO) : cours, positions et analyse de l'ETF

Bid66.07
Capitalisation boursièren / A
AUM201.57M
NAV66.66
Bêta0.97
EPS (ttm)n / A
Rapport PE (ttm)n / A
Parts en circulationn / A
Date de créationDec 30, 2014
Ask66.21
Volume18,785
Moy. Volume (20D)41,212
Ouverture66.77
Clôture précédente67.09
Fourchette du jour65.65 - 66.78
Intervalle de 52 semaines34.88 - 70.85
Positionsn / A
Ratio de frais0.50%

À propos de SBIO

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Classe d’actifs Equity
Symbole boursier SBIO
Date de création Dec 30, 2014
Fournisseur Alps
Échange NYSEArca

Principaux secteurs

SecteurPoids %
Healthcare100%
Voir tous les secteurs

10 principaux titres 32.28% des actifs

NomSymbolePoids
Crinetics Pharmaceut...CRNX4.75%
Apogee Therapeutics ...APGE4.48%
Cg Oncology IncCGON3.39%
Xenon Pharmaceutical...XENE3.26%
Dianthus Therapeutic...DNTH3.15%
Oruka Therapeutics I...ORKA3.14%
Travere Therapeutics...TVTX2.8%
Definium Therapeutic...DFTX2.56%
Acadia Pharmaceutica...ACAD2.39%
Veradermics IncMANE2.36%
Voir plus de titres

Dividendes Rendement du dividende 1.76%

Ex-dividendeMontantDate de paiement
Dec 19, 2024$1.1740n / A
Dec 21, 2023$0.0710n / A
Dec 19, 2019$0.0160n / A
Dec 20, 2018$0.7840n / A
Dec 21, 2017$0.5790n / A
Historique complet des dividendes